Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Bent von der Lippe

15 publications found

Original articles

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
Genome Biol, 15 (11), 490
DOI 10.1186/s13059-014-0490-3, PubMed 25418686

von der Lippe B, Sandven P, Brubakk O (2006)
Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases
J Infect, 52 (2), 92-6
DOI 10.1016/j.jinf.2005.04.007, PubMed 15907341

Myrvang B, von der Lippe B (2002)
[African trypanosomiasis--a rare imported disease]
Tidsskr Nor Laegeforen, 122 (1), 33-4
PubMed 11851292

Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, Godøy J, Dunlop O, von der Lippe B (2001)
Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis
Scand J Urol Nephrol, 35 (4), 330-3
DOI 10.1080/003655901750425945, PubMed 11676362

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
Scand J Gastroenterol, 34 (2), 194-8
DOI 10.1080/00365529950173087, PubMed 10192200

Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
Scand J Gastroenterol, 33 (2), 195-200
DOI 10.1080/00365529850166941, PubMed 9517532

Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
Scand J Infect Dis, 29 (1), 17-22
DOI 10.3109/00365549709008658, PubMed 9112292

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
Scand J Infect Dis, 28 (4), 357-9
DOI 10.3109/00365549609037919, PubMed 8893398

Skaug K, Hagen IJ, von der Lippe B (1994)
Three cases of acute hepatitis E virus infection imported into Norway
Scand J Infect Dis, 26 (2), 137-9
DOI 10.3109/00365549409011776, PubMed 8036468

Strand OA, von der Lippe B, Strømsheim J (1992)
[Pneumocystis carinii pneumonia--not only in AIDS]
Tidsskr Nor Laegeforen, 112 (22), 2841-2
PubMed 1412321

Review articles

Jensenius M, von der Lippe B, Melby K, Steinbakk M (1995)
[Proper use of antibiotics--what is that?]
Tidsskr Nor Laegeforen, 115 (28), 3504-7
PubMed 7491604

von der Lippe E, von der Lippe B (1995)
[Infections in intensive care units. A challenge for the specialist of infectious diseases?]
Tidsskr Nor Laegeforen, 115 (28), 3508-10
PubMed 7491605

Jensenius M, von der Lippe B, Melby K, Steinbakk M (1995)
[The end of antibiotics? Increasing bacterial resistance in global and Norwegian perspective]
Tidsskr Nor Laegeforen, 115 (27), 3382-6
PubMed 7491582